Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab

Clinical Rheumatology

Volumn 29, Issue 10, 2010, Pages 1191-1194

  Sumida, Keiichi ^a   Ubara, Yoshifumi ^a   Hoshino, Junichi ^a   Suwabe, Tatsuya ^a   Hiramatsu, Rikako ^a   Hasegawa, Eiko ^a   Hayami, Noriko ^a   Yamanouchi, Masayuki ^a   Sawa, Naoki ^a   Takemoto, Fumi ^a   Takaichi, Kenmei ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Adult onset Still's disease; Etanercept; Thrombotic thrombocytopenic purpura; Tocilizumab

Indexed keywords

INTERLEUKIN 6 RECEPTOR; MONOCLONAL ANTIBODY; TOCILIZUMAB;

ADULT ONSET STILL DISEASE; AGED; ARTICLE; CASE REPORT; DRUG ANTAGONISM; DRUG RESISTANCE; FEMALE; HUMAN; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; DRUG RESISTANCE; FEMALE; HUMANS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECEPTORS, INTERLEUKIN-6; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 79952108981     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-010-1418-2     Document Type: Article

References (15)

1. Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 65:564-572
2. Saiki O, Uda H, Nishimoto N et al (2004) Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile. Clin Immunol 112:120-125
3. Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still's disease. J Rheumatol 19:424-431
4. Bakshi R, Shaikh ZA, Bates VE et al (1999) Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology 52:1285-1288
5. Fautrel B, Sibilia J, Mariette X et al (2005) Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 64:262-266
6. Radstake TR, Svenson M, Eijsbouts AM et al (2009) Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. Ann Rheum Dis 68:1739-1745
7. Fitzgerald AA, Leclercq SA, Yan A et al (2005) Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 52:1794-1803
8. Matsumoto K, Nagashima T, Takatori S et al (2009) Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab. Clin Rheumatol 28:485-487
9. De Bandt M, Saint-Marcoux B (2009) Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 68:153-154
10. Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60:831-846
11. Furlan M, Robles R, Galbusera M et al (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578-1584
12. Sayarlioglu M, Sayarlioglu H, Ozkaya M et al (2008) Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome and adult onset Still's disease: case report and review of the literature. Mod Rheumatol 18:403-406
13. George JN (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354:1927-1935
14. Masson C, Myhal D, Menard H et al (1986) Purpura thrombotique thrombopenique fatal chez une patiente atteinte dune maladie de Still de I'adulte. Rev Rhum Mal Osteoartric 53:389-391
15. Domingues RB, da Gama AM, Caser EB et al (2003) Disseminated cerebral thrombotic microangiopathy in a patient with adult Still's disease. Arq Neuropsiquiatr 61:259-261